"Pacific Neuroscience Institute is devoted to the comprehensive care of patients with a wide spectrum of neurological and cranial disorders. Dedicated teams of specialists, state-of-the-art facilities and the use of leading-edge treatment along with our collaborative approach ensure that each patient receives the attention they require for successful treatment and recovery."

During the past decade, Neurological Research Inst conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurological Research Inst" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Cognition Therapeutics" with 1 trials sponsored, "EIP Pharma Inc" with 1 trials sponsored and "Mind Medicine, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Research Inst" #1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator, "The Emmes Company, LLC" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Neurological Research Inst" are "Alzheimer's Disease" (5 trials), "Anxiety Generalized" (1 trials), "Dementia With Lewy Bodies" (1 trials), "Dementia With Lewy Bodies (DLB)" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "Neurological Research Inst" in a lesser frequency.

Most popular intervention types in "Neurological Research Inst" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Crenezumab" (2 trials), "CT1812" (1 trials), "Donepezil" (1 trials) and "Galantamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Research Inst" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Neurological Research Inst". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Neurological Research Inst, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Research Inst, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".